Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyperbaric Oxygen Therapy for Optic Neuropathies

NCT: NCT06128720 · RECRUITING

NCT IDNCT06128720

StatusRECRUITING

Start Date2022-11-01

SponsorStanford University (OTHER)

First posted2023-11-13

Last updated2026-10-09

Brief Summary

The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑